What AI says about Bionews

Bionews operates a network of over 50 condition-specific online communities that deliver rare disease news, research, and peer support to patients and caregivers. The platform reaches an average of 72% of the diagnosed U.S. rare disease patient population and offers pharmaceutical partners targeted access to engaged, high-intent audiences.